Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 275

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 275
---
 Special Meeting, voting together as a single class. An abstention will be counted towards the quorum requirement but will not count as a vote cast at the Special Meeting. A broker non-vote will neither be counted towards the quorum requirement (as we believe the Advisory Charter Proposals will be considered as non-discretionary) nor count as a vote cast in the Special Meeting.

A copy of the Proposed ParentCo Certificate of Incorporation, as will be in effect and upon consummation of the Business Combination and filing with the Delaware Secretary of State, is attached to this proxy statement/prospectus as Annex C .

#### Recommendation of the Board

### THE IRIS BOARD UNANIMOUSLY RECOMMENDS THAT
<div align='center'>IRIS STOCKHOLDERS VOTE “FOR” EACH OF THE ADVISORY CHARTER PROPOSALS.

134</div>

TABLE OF CONTENTS

<div align='center'>**PROPOSAL NO. 6 — THE ELECTION OF DIRECTORS PROPOSAL**</div>

### Overview
Iris stockholders are being asked to consider, approve and confirm, on an advisory and non-binding basis, the appointment by the Iris Board of the following three directors to the ParentCo board of directors, effective upon the closing:

As a Class I director, with a term expiring at ParentCo’s 2026 annual meeting of stockholders: Mr. Nicholas Fernandez and Dr. Ji Yeon Baek .

As a Class II director, with a term expiring at ParentCo’s 2027 annual meeting of stockholders: Dr. Eun Sook Lee .

As a Class III director, with a term expiring at ParentCo’s 2028 annual meeting of stockholders: Mr. Chris Kim .

See “ Management of ParentCo following the Business Combination — Board Composition ” for more information.

Notwithstanding the approval of the Election of Directors Proposal, if the Business Combination is not consummated for any reason, the actions contemplated by the Election of Directors Proposal will not be effected.

Following consummation of the Business Combination, the election of directors of ParentCo will be governed by the ParentCo Certificate of Incorporation, the ParentCo bylaws and the laws of the State of Delaware. Pursuant to the terms of the ParentCo Certificate of Incorporation, the term of the Class I director will expire at the 2026 annual meeting of stockholders, the term of the Class II director will expire at the 2027 annual meeting of stockholders, and